603456:SSEZhejiang Jiuzhou Pharmaceutical Co., Ltd. Class A Analysis

Technical outlook: The stock is trading at CNY 12.99, well below its 20‑day (CNY 14.90), 50‑day (CNY 15.99) and 200‑day (CNY 18.05) simple moving averages, confirming a bearish trend. Momentum indicators are also weak – RSI sits at 23.8 (deeply oversold) and the MACD line remains under its signal, generating a bearish signal. However, price is hugging the identified support around CNY 12.95, suggesting a potential short‑term floor.
Fundamental outlook: Valuation appears attractive: the trailing P/E of 17.8 is markedly lower than the industry average of 27, and the DCF‑derived fair value of roughly CNY 19.0 implies the stock is undervalued by about 30%. The dividend yield of 3.81% is generous, with a payout ratio near 68% supported by solid operating cash flow, though free cash flow is negative. Volatility is high at 41.9% and the max drawdown of –40.6% signals considerable price swings, while beta is modest (0.33), indicating limited market‑wide sensitivity.